Turning the tide on drug progress expenses: How life sciences leaders can leverage clinical insights Conclusions: Golimumab won't seem to be equipped to keep up lengthy-term remission in UC in authentic life. The safety profile was great. The Editors have produced Journal of Gastroenterology and Hepatology into a world journal https://www.directivepublications.org/journal-of-digestive-and-liver-diseases/